21:40:52 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-04-03 Årsstämma 2025
2025-02-26 Bokslutskommuniké 2024
2024-11-07 Kvartalsrapport 2024-Q3
2024-08-28 Kvartalsrapport 2024-Q2
2024-05-03 Kvartalsrapport 2024-Q1
2024-05-01 Ordinarie utdelning NSIS B 2.00 DKK
2024-04-30 Årsstämma 2024
2024-03-04 Extra Bolagsstämma 2024
2024-02-08 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-10-13 Bonusutdelning NSIS B 4.2
2023-08-09 Kvartalsrapport 2023-Q2
2023-04-26 Kvartalsrapport 2023-Q1
2023-03-30 Extra Bolagsstämma 2023
2023-03-03 Ordinarie utdelning NSIS B 6.00 DKK
2023-03-02 Årsstämma 2023
2023-01-26 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-11 Kvartalsrapport 2022-Q2
2022-04-27 Kvartalsrapport 2022-Q1
2022-03-17 Ordinarie utdelning NSIS B 5.50 DKK
2022-03-16 Årsstämma 2022
2022-02-01 Bokslutskommuniké 2021
2021-10-27 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-12 Ordinarie utdelning NSIS B 5.25 DKK
2021-03-11 Årsstämma 2021
2021-02-02 Bokslutskommuniké 2020
2020-10-21 Kvartalsrapport 2020-Q3
2020-08-12 Kvartalsrapport 2020-Q2
2020-04-29 Kvartalsrapport 2020-Q1
2020-02-27 Ordinarie utdelning NSIS B 5.25 DKK
2020-02-26 Årsstämma 2020
2020-01-23 Bokslutskommuniké 2019
2019-10-23 Kvartalsrapport 2019-Q3
2019-08-08 Kvartalsrapport 2019-Q2
2019-04-24 Kvartalsrapport 2019-Q1
2019-02-28 Ordinarie utdelning NSIS B 5.00 DKK
2019-02-27 Årsstämma 2019
2019-01-24 Bokslutskommuniké 2018
2018-10-24 Kvartalsrapport 2018-Q3
2018-08-10 Kvartalsrapport 2018-Q2
2018-04-25 Kvartalsrapport 2018-Q1
2018-03-14 Ordinarie utdelning NSIS B 4.50 DKK
2018-03-13 Årsstämma 2018
2018-02-07 Bokslutskommuniké 2017
2017-10-25 Kvartalsrapport 2017-Q3
2017-08-11 Kvartalsrapport 2017-Q2
2017-04-26 Kvartalsrapport 2017-Q1
2017-02-23 Ordinarie utdelning NSIS B 4.00 DKK
2017-02-22 Årsstämma 2017
2017-01-18 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-10 Kvartalsrapport 2016-Q2
2016-04-20 Kvartalsrapport 2016-Q1
2016-02-25 Ordinarie utdelning NSIS B 3.50 DKK
2016-02-24 Årsstämma 2016
2016-01-19 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-08-06 Kvartalsrapport 2015-Q2
2015-04-23 Kvartalsrapport 2015-Q1
2015-02-26 Ordinarie utdelning NSIS B 3.00 DKK
2015-02-25 Årsstämma 2015
2015-01-20 Bokslutskommuniké 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-08-14 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-02-27 Ordinarie utdelning NSIS B 2.50 DKK
2014-02-26 Årsstämma 2014
2014-01-21 Bokslutskommuniké 2013
2013-10-25 Kvartalsrapport 2013-Q3
2013-08-09 Kvartalsrapport 2013-Q2
2013-04-25 Kvartalsrapport 2013-Q1
2013-03-01 Ordinarie utdelning NSIS B 2.20 DKK
2013-02-28 Årsstämma 2013
2012-10-25 Kvartalsrapport 2012-Q3
2012-08-16 Kvartalsrapport 2012-Q2
2012-04-25 Kvartalsrapport 2012-Q1
2012-03-01 Ordinarie utdelning NSIS B 1.90 DKK
2012-02-29 Årsstämma 2012
2012-01-19 Bokslutskommuniké 2011
2011-11-28 Split NSIS B 1:5
2011-10-28 Kvartalsrapport 2011-Q3
2011-08-11 Kvartalsrapport 2011-Q2
2011-04-29 Kvartalsrapport 2011-Q1
2011-03-03 Ordinarie utdelning NSIS B 8.00 DKK
2011-03-02 Årsstämma 2011
2011-01-21 Bokslutskommuniké 2010
2010-10-28 Kvartalsrapport 2010-Q3
2010-08-12 Kvartalsrapport 2010-Q2
2010-04-29 Kvartalsrapport 2010-Q1
2010-03-04 Ordinarie utdelning NSIS B 5.75 DKK
2010-03-03 Årsstämma 2010
2009-03-05 Ordinarie utdelning NSIS B 5.25 DKK
2008-03-06 Ordinarie utdelning NSIS B 5.00 DKK
2007-03-09 Ordinarie utdelning NSIS B 4.50 DKK
2006-03-02 Ordinarie utdelning NSIS B 4.00 DKK
2005-03-17 Ordinarie utdelning NSIS B 3.50 DKK
2004-03-18 Ordinarie utdelning NSIS B 3.15 DKK
2003-03-20 Ordinarie utdelning NSIS B 2.25 DKK
2002-03-21 Ordinarie utdelning NSIS B 2.00 DKK
2001-03-22 Ordinarie utdelning NSIS B 1.65 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Novonesis är verksamma inom biokemi. Bolaget utvecklar enzymer och mikroorganismer för industriellt bruk. Enzymerna är ett protein som används inom ett flertal olika branscher, huvudsakligen inom jordbruks- och livsmedelsindustrin. Produkterna används inom livsmedel samt kläder, och försäljning innehas på global nivå, med störst närvaro inom Norden och Europa. Bolaget har sitt huvudkontor i Bagsværd.
2022-11-01 17:00:10

Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year

World’s Leading Biotech Powerhouse Recognized for Providing and Advocating for Ingredients that Create Safer Detergents

Franklinton, NCNovember 1, 2022. Novozymes was named a 2022 Safer Choice® Partner of the Year by the U.S. Environmental Protection Agency (EPA) for outstanding achievement in the manufacture of ingredients that are safer for families, pets, workplaces, communities, and the environment. Novozymes is among the 26 Safer Choice Partner of the Year award winners announced by the EPA in 2022. 

The Safer Choice program helps consumers and purchasers for facilities, such as schools and office buildings, find products that perform and are safer for human health and the environment. Novozymes’ recognition is based on the company’s innovative approach to creating enzymes to be incorporated into safer detergents, and for spreading awareness of Safer Choice advocating for use of Safer Choice ingredients.

“We are proud to again be receiving this recognition as a Safer Choice Partner,” said Arnaud Melin, VP of Consumer Biosolutions, Americas, at Novozymes. “Alongside our industry partners we’re striving to build the next generation of cleaning products, starting with laundry detergents, to reduce chemical and carbon footprints by leveraging sustainable, biological solutions.”

Decarbonization of the cleaning industry is one of the key goals for Novozymes’ biological detergent initiative. Typically, detergents are made of ingredients such as surfactants, polymers, and solvents. These fossil-derived chemical ingredients can account for up to 46% of a detergent’s carbon footprint. But Novozymes enzymes can partially replace the chemicals in laundry detergents with more climate-friendly biobased ingredients.​

Consumers and purchasers are increasingly asking for eco-friendly products that are gentler on the planet and for end-users. The Safer Choice program makes it easier for people to identify the products that achieve that, while not compromising on performance and cost. “We are proud to recognize Novozymes North America in Raleigh, North Carolina for their work to manufacture safer chemicals in a sustainable manner," said EPA Region 4 Administrator Daniel Blackman. “Their achievements in promoting the Safer Choice program and supporting formulators to become Safer Choice certified ultimately provides consumers and commercial buyers with products that are safer for communities and the environment.”

Novozymes is on an ambitious journey to enable biological detergents without compromising wash performance and cost. The company continues to build its product portfolio to help industry partners to launch U.S. EPA Safer Choice approved consumer products. In 2021, Novozymes added seven ingredients to CleanGredients, a database of chemical ingredients pre-approved for use in Safer Choice-certified products, including its latest innovation to remove body grime from clothes, Pristine® 100 T. Novozymes supported 12 requests made by formulators and brand owners for certification of formulations by the Safer Choice program. Novozymes also leveraged owned media to promote both the U.S. EPA Safer Choice program, as well as Novozymes’ product lines that enable formulators and retailers to offer cleaning products that carry the Safer Choice logo.

The company also ran a survey of 1,000 consumers in the United States to gather data on consumer perception of Safer Choice as the most trustworthy certification on laundry products. Novozymes provided this information to formulators to help them understand how Safer Choice certification enables commercial success. Novozymes showed its commitment to EPA’s goal of addressing climate change by working to reduce carbon emissions. Novozymes has also committed to ensuring zero waste by 2030. The company is well on its way to this goal, with a recycling rate of non-biomass waste at 62% in 2021, compared to 48% in 2020. The company also successfully advocated within the Household & Commercial Products Association (HCPA) and the Sustainable Chemistry Alliance (SCA) for those organizations to prioritize supporting Safer Choice.

“Our company purpose states ‘Together, we find biological answers for better lives in a growing world.’ A vital element of this is not just doing our part with our own products, but also educating and empowering others, whether that be our commercial customers, the organizations we partner with, or the general public, to explore and adopt these solutions’” said Melin. “We understood that formulators, retailers, and consumers need to build awareness toward both U.S. EPA Safer Choice and Novozymes’ Safer Choice product lines easily in order to build product formulations that are environmentally friendly. Striving for and earning that Safer Choice standard demonstrates a commitment to rethinking tomorrow.”

To qualify for the Safer Choice label, a product must meet EPA’s Safer Choice Standard, which includes stringent human and environmental health criteria. The Safer Choice program currently partners with about 350 formulator-manufacturer partners who make nearly 2,000 Safer Choice-certified products for both consumers and commercial buyers. 

More information on the 2022 Safer Choice Partner of the Year Award winners can be found at www.epa.gov/saferchoice/safer-choice-partner-year-awardsClick here for the Novozymes Safer Choice Partner of the Year video.

About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

NASDAQ OMX: NZYM-B • 6,500 employees • DKK 15 billion turnover • 30+ industries • 700+ products

   
Media Relations  
   
Lina Danstrup  
Head of Media Relations 
Phone: +45 30 77 05 52 
lind@novozymes.com     



Kathy Humphrey
Head of Communications, North America
Phone: 919-494-8764
khp@novozymes.com
  
   

World’s Leading Biotech Powerhouse Recognized for Providing and Advocating for Ingredients that Create Safer Detergents

Franklinton, NC – November 1, 2022. Novozymes was named a 2022 Safer Choice® Partner of the Year by the U.S. Environmental Protection Agency (EPA) for outstanding achievement in the manufacture of ingredients that are safer for families, pets, workplaces, communities, and the environment. Novozymes is among the 26 Safer Choice Partner of the Year award winners announced by the EPA in 2022. 

The Safer Choice program helps consumers and purchasers for facilities, such as schools and office buildings, find products that perform and are safer for human health and the environment. Novozymes’ recognition is based on the company’s innovative approach to creating enzymes to be incorporated into safer detergents, and for spreading awareness of Safer Choice advocating for use of Safer Choice ingredients.

“We are proud to again be receiving this recognition as a Safer Choice Partner,” said Arnaud Melin, VP of Consumer Biosolutions, Americas, at Novozymes. “Alongside our industry partners we’re striving to build the next generation of cleaning products, starting with laundry detergents, to reduce chemical and carbon footprints by leveraging sustainable, biological solutions.”

Decarbonization of the cleaning industry is one of the key goals for Novozymes’ biological detergent initiative. Typically, detergents are made of ingredients such as surfactants, polymers, and solvents. These fossil-derived chemical ingredients can account for up to 46% of a detergent’s carbon footprint. But Novozymes enzymes can partially replace the chemicals in laundry detergents with more climate-friendly biobased ingredients.​

Consumers and purchasers are increasingly asking for eco-friendly products that are gentler on the planet and for end-users. The Safer Choice program makes it easier for people to identify the products that achieve that, while not compromising on performance and cost. “We are proud to recognize Novozymes North America in Raleigh, North Carolina for their work to manufacture safer chemicals in a sustainable manner," said EPA Region 4 Administrator Daniel Blackman. “Their achievements in promoting the Safer Choice program and supporting formulators to become Safer Choice certified ultimately provides consumers and commercial buyers with products that are safer for communities and the environment.”

Novozymes is on an ambitious journey to enable biological detergents without compromising wash performance and cost. The company continues to build its product portfolio to help industry partners to launch U.S. EPA Safer Choice approved consumer products. In 2021, Novozymes added seven ingredients to CleanGredients, a database of chemical ingredients pre-approved for use in Safer Choice-certified products, including its latest innovation to remove body grime from clothes, Pristine® 100 T. Novozymes supported 12 requests made by formulators and brand owners for certification of formulations by the Safer Choice program. Novozymes also leveraged owned media to promote both the U.S. EPA Safer Choice program, as well as Novozymes’ product lines that enable formulators and retailers to offer cleaning products that carry the Safer Choice logo.

The company also ran a survey of 1,000 consumers in the United States to gather data on consumer perception of Safer Choice as the most trustworthy certification on laundry products. Novozymes provided this information to formulators to help them understand how Safer Choice certification enables commercial success. Novozymes showed its commitment to EPA’s goal of addressing climate change by working to reduce carbon emissions. Novozymes has also committed to ensuring zero waste by 2030. The company is well on its way to this goal, with a recycling rate of non-biomass waste at 62% in 2021, compared to 48% in 2020. The company also successfully advocated within the Household & Commercial Products Association (HCPA) and the Sustainable Chemistry Alliance (SCA) for those organizations to prioritize supporting Safer Choice.

“Our company purpose states ‘Together, we find biological answers for better lives in a growing world.’ A vital element of this is not just doing our part with our own products, but also educating and empowering others, whether that be our commercial customers, the organizations we partner with, or the general public, to explore and adopt these solutions’” said Melin. “We understood that formulators, retailers, and consumers need to build awareness toward both U.S. EPA Safer Choice and Novozymes’ Safer Choice product lines easily in order to build product formulations that are environmentally friendly. Striving for and earning that Safer Choice standard demonstrates a commitment to rethinking tomorrow.”

To qualify for the Safer Choice label, a product must meet EPA’s Safer Choice Standard, which includes stringent human and environmental health criteria. The Safer Choice program currently partners with about 350 formulator-manufacturer partners who make nearly 2,000 Safer Choice-certified products for both consumers and commercial buyers. 

More information on the 2022 Safer Choice Partner of the Year Award winners can be found at www.epa.gov/saferchoice/safer-choice-partner-year-awardsClick here for the Novozymes Safer Choice Partner of the Year video.

About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

NASDAQ OMX: NZYM-B • 6,500 employees • DKK 15 billion turnover • 30+ industries • 700+ products

 

 
  
Media Relations  
   
Lina Danstrup  
Head of Media Relations 
Phone: +45 30 77 05 52 
lind@novozymes.com    

 

Kathy Humphrey
Head of Communications, North America
Phone: 919-494-8764
khp@novozymes.com